Embla Medical hf (OSSFF)
4.55
+0.40
(+9.64%)
USD |
OTCM |
Aug 27, 16:00
Embla Medical hf EPS Diluted (Quarterly) : 0.0686 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0686 |
| March 31, 2026 | 0.0338 |
| December 31, 2025 | 0.057 |
| September 30, 2025 | 0.0608 |
| June 30, 2025 | 0.049 |
| March 31, 2025 | 0.0285 |
| December 31, 2024 | 0.0426 |
| September 30, 2024 | 0.0512 |
| June 30, 2024 | 0.0467 |
| March 31, 2024 | 0.0193 |
| December 31, 2023 | 0.0452 |
| September 30, 2023 | 0.0331 |
| June 30, 2023 | 0.0375 |
| March 31, 2023 | 0.0231 |
| December 31, 2022 | 0.0307 |
| September 30, 2022 | 0.0161 |
| June 30, 2022 | 0.0335 |
| March 31, 2022 | 0.0208 |
| December 31, 2021 | 0.0416 |
| September 30, 2021 | 0.0396 |
| June 30, 2021 | 0.044 |
| March 31, 2021 | 0.0264 |
| December 31, 2020 | 0.0081 |
| September 30, 2020 | 0.0342 |
| June 30, 2020 | -0.0433 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0158 |
| December 31, 2019 | 0.0403 |
| September 30, 2019 | 0.033 |
| June 30, 2019 | 0.0511 |
| March 31, 2019 | 0.0318 |
| December 31, 2018 | 0.08 |
| September 30, 2018 | 0.037 |
| June 30, 2018 | 0.046 |
| March 31, 2018 | 0.0238 |
| December 31, 2017 | 0.054 |
| September 30, 2017 | 0.026 |
| June 30, 2017 | 0.03 |
| March 31, 2017 | 0.024 |
| December 31, 2016 | 0.033 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.033 |
| March 31, 2016 | 0.02 |
| December 31, 2015 | 0.028 |
| September 30, 2015 | 0.031 |
| June 30, 2015 | 0.035 |
| March 31, 2015 | 0.02 |
| December 31, 2014 | 0.033 |
| September 30, 2014 | 0.035 |
| June 30, 2014 | 0.038 |
| March 31, 2014 | 0.025 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
| Intuitive Surgical, Inc. | 2.290 |
| Kewaunee Scientific Corp. | 1.131 |
| STAAR Surgical Co. | 0.1565 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 29.32M |
| Revenue (Quarterly) | 258.57M |
| Total Expenses (Quarterly) | 229.35M |
| Enterprise Value | 2.378B |
| Gross Profit Margin (Quarterly) | 59.26% |
| Profit Margin (Quarterly) | 11.34% |
| Earnings Yield | 4.84% |
| Operating Earnings Yield | 6.89% |
| Normalized Earnings Yield | 4.842 |